Search research articles
Contact Us
Filters
Showing results (91-100 of 111) with videos related to
Page
of 12
Sort By:
Biochemical Pharmacology
|
December 15, 1990
Enhancement of bradykinin-induced prostacyclin synthesis in porcine aortic endothelial cells by pertussis toxin. Possible implication of lipocortin I
M Fujimoto, T Sakata, Y Tsuruta, et al.
Journal of Cardiovascular Pharmacology
|
July 21, 1999
Pharmacological characterization of PABSA, an orally active and highly potent endothelin-receptor antagonist
T Iwasaki, S Mihara, T Shimamura, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
December 1, 1991
[A clinical survey of advanced bladder cancer: treatment of advanced and non-resectable bladder cancer]
K Naito, T Hasegawa, T Ishida, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 13, 1999
Effects of thyroid hormones on apoptotic cell death of human lymphocytes
S Mihara, N Suzuki, S Wakisaka, et al.
Chemical & Pharmaceutical Bulletin
|
November 1, 1988
Studies on dihydropyridines. III. Synthesis of 4,7-dihydrothieno [2,3-b]-pyridines with vasodilator and antihypertensive activities
I Adachi, T Yamamori, Y Hiramatsu, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
December 1, 1991
[End-stage chronic renal failure in patients treated by antireflux operation]
S Tokunaga, M Ohkawa, H Yamamoto, et al.
Thrombosis Research
|
January 15, 1988
Effects of latamoxef on in vitro and ex vivo thromboxane A2 generation in human platelets
S Mihara, H Kakushi, T Shike, et al.
Nephron
|
January 1, 1995
Diagnostic revolution of microhematuria by real time confocal scanning laser microscope: Hyodo-Iino-Miyagawa method, third report
T Hyodo, I Miyagawa, A Iino, et al.
Journal of Cardiovascular Pharmacology
|
April 13, 2001
Pharmacologic characterization of S-1255, a highly potent and orally active endothelin A receptor antagonist
T Iwasaki, S Mihara, T Shimamura, et al.
The Journal of Rheumatology
|
February 7, 1998
Mechanisms of KE298, 2-acetylthiomethyl-3-(4-methylbenzoyl) propionic acid, to suppress abnormal synovial cell functions in patients with rheumatoid arthritis
T Sakane, N Suzuki, Y Hirose, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 111) with videos related to
Sort By:
Page
of 12
Biochemical Pharmacology
|
December 15, 1990
Enhancement of bradykinin-induced prostacyclin synthesis in porcine aortic endothelial cells by pertussis toxin. Possible implication of lipocortin I
M Fujimoto, T Sakata, Y Tsuruta, et al.
Journal of Cardiovascular Pharmacology
|
July 21, 1999
Pharmacological characterization of PABSA, an orally active and highly potent endothelin-receptor antagonist
T Iwasaki, S Mihara, T Shimamura, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
December 1, 1991
[A clinical survey of advanced bladder cancer: treatment of advanced and non-resectable bladder cancer]
K Naito, T Hasegawa, T Ishida, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 13, 1999
Effects of thyroid hormones on apoptotic cell death of human lymphocytes
S Mihara, N Suzuki, S Wakisaka, et al.
Chemical & Pharmaceutical Bulletin
|
November 1, 1988
Studies on dihydropyridines. III. Synthesis of 4,7-dihydrothieno [2,3-b]-pyridines with vasodilator and antihypertensive activities
I Adachi, T Yamamori, Y Hiramatsu, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
December 1, 1991
[End-stage chronic renal failure in patients treated by antireflux operation]
S Tokunaga, M Ohkawa, H Yamamoto, et al.
Thrombosis Research
|
January 15, 1988
Effects of latamoxef on in vitro and ex vivo thromboxane A2 generation in human platelets
S Mihara, H Kakushi, T Shike, et al.
Nephron
|
January 1, 1995
Diagnostic revolution of microhematuria by real time confocal scanning laser microscope: Hyodo-Iino-Miyagawa method, third report
T Hyodo, I Miyagawa, A Iino, et al.
Journal of Cardiovascular Pharmacology
|
April 13, 2001
Pharmacologic characterization of S-1255, a highly potent and orally active endothelin A receptor antagonist
T Iwasaki, S Mihara, T Shimamura, et al.
The Journal of Rheumatology
|
February 7, 1998
Mechanisms of KE298, 2-acetylthiomethyl-3-(4-methylbenzoyl) propionic acid, to suppress abnormal synovial cell functions in patients with rheumatoid arthritis
T Sakane, N Suzuki, Y Hirose, et al.
Page
of 12